The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $12.32 in the prior trading day, Replimune Group Inc (NASDAQ: REPL) closed at $2.81, down -77.24%. In other words, the price has decreased by -$77.24 from its previous closing price. On the day, 85.37 million shares were traded. REPL stock price reached its highest trading level at $3.56 during the session, while it also had its lowest trading level at $2.68.
Ratios:
Our goal is to gain a better understanding of REPL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.95 and its Current Ratio is at 7.95. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
On July 22, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $3.
Leerink Partners Downgraded its Outperform to Market Perform on July 22, 2025, while the target price for the stock was maintained at $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 20 ’25 when Astley-Sparke Philip sold 32,279 shares for $8.06 per share. The transaction valued at 260,169 led to the insider holds 1,405,071 shares of the business.
Xynos Konstantinos sold 7,952 shares of REPL for $64,093 on May 20 ’25. The Chief Medical Officer now owns 146,933 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Schwendenman Andrew, who serves as the Chief Accounting Officer of the company, sold 3,287 shares for $8.05 each. As a result, the insider received 26,460 and left with 68,284 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 216228480 and an Enterprise Value of 542455168.
Stock Price History:
The Beta on a monthly basis for REPL is 0.70, which has changed by -0.7263415 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $6.44. The 50-Day Moving Average of the stock is -70.28%, while the 200-Day Moving Average is calculated to be -74.55%.
Shares Statistics:
The stock has traded on average 1.57M shares per day over the past 3-months and 11516810 shares per day over the last 10 days, according to various share statistics. A total of 77.09M shares are outstanding, with a floating share count of 62.53M. Insiders hold about 18.88% of the company’s shares, while institutions hold 93.95% stake in the company. Shares short for REPL as of 1751241600 were 9898243 with a Short Ratio of 6.31, compared to 1748563200 on 8506572. Therefore, it implies a Short% of Shares Outstanding of 9898243 and a Short% of Float of 17.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
